Longevity gene under cloud of doubts
A trans-Atlantic dispute has opened up between two camps of researchers pursuing a gene that could lead to drugs that enhance longevity.
British scientists say the longevity gene is "nearing the end of its life," but the Americans whose work is under attack say the approach remains as promising as ever. The dispute concerns genes that make sirtuins, proteins involved in controlling cells' metabolism.